Skip to Content

Dr. Emily Place to present at TIDES USA event in San Diego

April 20, 2023  •  News  •  Kris Kraihanzel
Posted In Other News & Insights, Biologics News & Insights – Biologics Consulting

Presentation Title: Key Elements of a Well Composed Nonclinical Section of an IND Application

 New oligonucleotide therapeutics under investigation offer unique challenges relative to other pharmaceuticals. During preparation and submission of an investigational new drug (IND) application there are a number of regulatory gray areas due to the large heterogeneity in the type of oligonucleotide therapeutics and our knowledge of any particular subclass. Based on lessons learned, this talk will describe selected general considerations to a successful non-clinical IND submission.